menu
    • menu

    Company profile for Ensysce Biosciences

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ensysce intends to launch the first new class of Opioid analgesics in decades —limiting the chances for abuse while alleviating pain. We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs ass...
    Ensysce intends to launch the first new class of Opioid analgesics in decades —limiting the chances for abuse while alleviating pain. We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ensysce BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3210 Merryfield Row San Diego, CA 92121
    Telephone
    Telephone
    (858) 242-1553
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ensysce.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ensysce Expands Overdose Protection Patent Coverage
    Ensysce Expands Overdose Protection Patent Coverage

    12 May 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ensysce-biosciences-announces-expansion-of-patent-protection-for-grou-1165814

    ACCESSWIRE
    12 May 2026
    Share Share
    Ensysce CEO Presents at Inaugural Clinical Pain Symposium
    Ensysce CEO Presents at Inaugural Clinical Pain Symposium

    08 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-08/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain-symposium-in-amsterdam

    PHARMIWEB
    08 May 2026
    Share Share
    Ensysce Gets IRB Nod for Final Phase of PF614-MPAR-102
    Ensysce Gets IRB Nod for Final Phase of PF614-MPAR-102

    16 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-16/ensysce-biosciences-secures-irb-approval-of-final-phase-of-pf614-mpar-102-clinical-study

    PHARMIWEB
    16 Apr 2026
    Share Share
    Ensysce Bio Secures 2Nd Financing To Advance Pain Programs
    Ensysce Bio Secures 2Nd Financing To Advance Pain Programs

    07 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-07/ensysce-biosciences-secures-second-financing-from-2025-agreement-to-advance-breakthrough-pain-progra

    PHARMIWEB
    07 Apr 2026
    Share Share
    Ensysce Bio Reports Q4 & Full Year 2025 Financial Results
    Ensysce Bio Reports Q4 & Full Year 2025 Financial Results

    30 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-30/ensysce-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results

    PHARMIWEB
    30 Mar 2026
    Share Share
    Ensysce Biosciences Launches Live (AMA) Showcasing Growth
    Ensysce Biosciences Launches Live (AMA) Showcasing Growth

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/ensysce-biosciences-initiates-live-ask-me-anything-ama-session-highlighting-growth-and-future-pl

    PHARMIWEB
    04 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search